Conference Coverage
Conference Coverage
ECMO for shock in acute MI won’t help, may harm: ECLS-SHOCK
Risks for moderate or severe bleeding more than doubled and serious peripheral vascular complications almost tripled with addition of ECMO support...
Conference Coverage
Wegovy scores HFpEF benefits in people with obesity
The results “indicate that treatment with semaglutide is a valuable therapeutic approach in the management of patients with HFpEF and obesity.”
Conference Coverage
Daily statin cuts cardiovascular risk in HIV
“These are types of people who, if they came to the doctor’s office right now before REPRIEVE, they would largely be told your risk score is not...
Latest News
Experts call for early screening for chronic kidney disease
Nearly all patients seen in primary care are candidates for screening because of their risk factors for kidney disease, such as diabetes and...
Conference Coverage
Global burden of brain disorders surpasses cardiovascular disease and cancer
“The burden of brain conditions will increase as populations continue to grow and age.”
Conference Coverage
New ESH hypertension guidelines aim for simplified message
A new feature of the guidelines is the upgrading of beta-blockers in the treatment algorithms.
Latest News
Residency match process under scrutiny again, this time by AMA
AMA may study alternatives to the current residency matching program in an effort to improve residents’ compensation and other job-related issues...
Conference Coverage
OASIS and PIONEER PLUS support high-dose oral semaglutide
OASIS-1 showed that “oral semaglutide 50 mg may represent an effective option for the treatment of obesity, particularly in patients who prefer...
Conference Coverage
‘Striking’ benefit of lipid lowering in primary prevention
“If patients can’t tolerate a statin, then treat them with bempedoic acid. The bottom line is that these patients just need to be treated.”
Conference Coverage
SURMOUNT-2: Tirzepatide rings up major weight loss in type 2 diabetes
Taken together, results from SURMOUNT-1 and SURMOUNT-2 appear to make a good case for a weight-loss indication that will not depend on whether a...
Conference Coverage
Upping CO2 does not benefit OHCA patients: TAME
“These out-of-hospital cardiac arrest patients are a very diverse group, and it may be possible that some patients could have benefited from...